ID   AQP2_HUMAN              Reviewed;         271 AA.
AC   P41181; Q9UD68;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Aquaporin-2;
DE            Short=AQP-2;
DE   AltName: Full=ADH water channel;
DE   AltName: Full=Aquaporin-CD;
DE            Short=AQP-CD;
DE   AltName: Full=Collecting duct water channel protein;
DE   AltName: Full=WCH-CD;
DE   AltName: Full=Water channel protein for renal collecting duct;
GN   Name=AQP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8140421; DOI=10.1126/science.8140421;
RA   Deen P.M.T., Verdijk M.A.J., Knoers V.V.A.M., Wieringa B.,
RA   Monnens L.A.H., van Os C.H., van Oost B.A.;
RT   "Requirement of human renal water channel aquaporin-2 for vasopressin-
RT   dependent concentration of urine.";
RL   Science 264:92-94(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7522228;
RA   Uchida S., Sasaki S., Fushimi K., Marumo F.;
RT   "Isolation of human aquaporin-CD gene.";
RL   J. Biol. Chem. 269:23451-23455(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ANDI ARG-64; CYS-187 AND
RP   PRO-216.
RX   PubMed=7524315;
RA   van Lieburg A.F., Verdijk M.A.J., Knoers V.V.A.M., van Essen A.J.,
RA   Proesmans W., Mallmann R., Monnens L.A.H., van Oost B.A., van Os C.H.,
RA   Deen P.M.T.;
RT   "Patients with autosomal nephrogenic diabetes insipidus homozygous for
RT   mutations in the aquaporin 2 water-channel gene.";
RL   Am. J. Hum. Genet. 55:648-652(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Kidney;
RX   PubMed=7510718; DOI=10.1172/JCI117079;
RA   Sasaki S., Fushimi K., Saito H., Saito F., Uchida S., Ishibashi K.,
RA   Kuwahara M., Ikeuchi T., Inui K., Nakajima K.;
RT   "Cloning, characterization, and chromosomal mapping of human aquaporin
RT   of collecting duct.";
RL   J. Clin. Invest. 93:1250-1256(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Kidney;
RX   PubMed=11929850; DOI=10.1093/hmg/11.7.779;
RA   Marr N., Bichet D.G., Lonergan M., Arthus M.-F., Jeck N.,
RA   Seyberth H.W., Rosenthal W., van Os C.H., Oksche A., Deen P.M.T.;
RT   "Heteroligomerization of an aquaporin-2 mutant with wild-type
RT   aquaporin-2 and their misrouting to late endosomes/lysosomes explains
RT   dominant nephrogenic diabetes insipidus.";
RL   Hum. Mol. Genet. 11:779-789(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-256, AND MUTAGENESIS OF
RP   SER-148; SER-229; SER-231; THR-244 AND SER-256.
RX   PubMed=12194985; DOI=10.1074/jbc.M207525200;
RA   van Balkom B.W.M., Savelkoul P.J.M., Markovich D., Hofman E.,
RA   Nielsen S., van der Sluijs P., Deen P.M.T.;
RT   "The role of putative phosphorylation sites in the targeting and
RT   shuttling of the aquaporin-2 water channel.";
RL   J. Biol. Chem. 277:41473-41479(2002).
RN   [8]
RP   VARIANT ANDI CYS-202.
RX   PubMed=8882880; DOI=10.1007/s004390050264;
RA   Oksche A., Moeller A., Dickson J., Rosendahl W., Rascher W.,
RA   Bichet D.G., Rosenthal W.;
RT   "Two novel mutations in the aquaporin-2 and the vasopressin V2
RT   receptor genes in patients with congenital nephrogenic diabetes
RT   insipidus.";
RL   Hum. Genet. 98:587-589(1996).
RN   [9]
RP   VARIANTS ANDI VAL-22 AND TRP-181.
RX   PubMed=9302264; DOI=10.1093/hmg/6.11.1865;
RA   Canfield M.C., Tamarappoo B.K., Moses A.M., Verkman A.S.,
RA   Holtzman E.J.;
RT   "Identification and characterization of aquaporin-2 water channel
RT   mutations causing nephrogenic diabetes insipidus with partial
RT   vasopressin response.";
RL   Hum. Mol. Genet. 6:1865-1871(1997).
RN   [10]
RP   VARIANTS ANDI SER-68; MET-126 AND THR-147.
RX   PubMed=9048343;
RA   Mulders S.M., Knoers N.V., Van Lieburg A.F., Monnens L.A., Leumann E.,
RA   Wuhl E., Schober E., Rijss J.P.L., Van Os C.H., Deen P.M.T.;
RT   "New mutations in the AQP2 gene in nephrogenic diabetes insipidus
RT   resulting in functional but misrouted water channels.";
RL   J. Am. Soc. Nephrol. 8:242-248(1997).
RN   [11]
RP   VARIANTS ANDI MET-168 AND PRO-216.
RX   PubMed=9402087;
RA   Vargas-Poussou R., Forestier L., Dautzenberg M.D., Niaudet P.,
RA   Dechaux M., Antignac C.;
RT   "Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12
RT   families with congenital nephrogenic diabetes insipidus.";
RL   J. Am. Soc. Nephrol. 8:1855-1862(1997).
RN   [12]
RP   VARIANTS ANDI MET-125; ARG-175; THR-190 AND LEU-262.
RX   PubMed=9550615;
RA   Kuwahara M.;
RT   "Aquaporin-2, a vasopressin-sensitive water channel, and nephrogenic
RT   diabetes insipidus.";
RL   Intern. Med. 37:215-217(1998).
RN   [13]
RP   VARIANT ANDI LYS-258.
RX   PubMed=9649557; DOI=10.1172/JCI2605;
RA   Mulders S.M., Bichet D.G., Rijss J.P.L., Kamsteeg E.-J., Arthus M.-F.,
RA   Lonergan M., Fujiwara M., Morgan K., Leijendekker R.,
RA   van der Sluijs P., van Os C.H., Deen P.M.T.;
RT   "An aquaporin-2 water channel mutant which causes autosomal dominant
RT   nephrogenic diabetes insipidus is retained in the Golgi complex.";
RL   J. Clin. Invest. 102:57-66(1998).
RN   [14]
RP   VARIANTS ANDI MET-125 AND ARG-175.
RX   PubMed=9745427; DOI=10.1210/jcem.83.9.5074;
RA   Goji K., Kuwahara M., Gu Y., Matsuo M., Marumo F., Sasaki S.;
RT   "Novel mutations in aquaporin-2 gene in female siblings with
RT   nephrogenic diabetes insipidus: evidence of disrupted water channel
RT   function.";
RL   J. Clin. Endocrinol. Metab. 83:3205-3209(1998).
RN   [15]
RP   VARIANTS ANDI PRO-28; VAL-47; MET-71; MET-125; ARG-175 AND ALA-185,
RP   AND VARIANT ILE-194.
RX   PubMed=12191971; DOI=10.1097/01.ASN.0000027355.41663.14;
RA   Marr N., Bichet D.G., Hoefs S., Savelkoul P.J.M., Konings I.B.,
RA   De Mattia F., Graat M.P., Arthus M.-F., Lonergan M., Fujiwara T.M.,
RA   Knoers N.V., Landau D., Balfe W.J., Oksche A., Rosenthal W.,
RA   Muller D., Van Os C.H., Deen P.M.;
RT   "Cell-biologic and functional analyses of five new Aquaporin-2
RT   missense mutations that cause recessive nephrogenic diabetes
RT   insipidus.";
RL   J. Am. Soc. Nephrol. 13:2267-2277(2002).
RN   [16]
RP   VARIANTS ANDI PRO-57 AND VAL-100.
RX   PubMed=12050236; DOI=10.1210/jcem.87.6.8617;
RA   Lin S.H., Bichet D.G., Sasaki S., Kuwahara M., Arthus M.-F.,
RA   Lonergan M., Lin Y.-F.;
RT   "Two novel aquaporin-2 mutations responsible for congenital
RT   nephrogenic diabetes insipidus in Chinese families.";
RL   J. Clin. Endocrinol. Metab. 87:2694-2700(2002).
RN   [17]
RP   VARIANTS ANDI CYS-187; THR-190 AND LEU-262, AND CHARACTERIZATION OF
RP   VARIANTS ANDI CYS-187; THR-190 AND LEU-262.
RX   PubMed=15509592; DOI=10.1093/hmg/ddh339;
RA   de Mattia F., Savelkoul P.J.M., Bichet D.G., Kamsteeg E.-J.,
RA   Konings I.B.M., Marr N., Arthus M.-F., Lonergan M., van Os C.H.,
RA   van der Sluijs P., Robertson G., Deen P.M.T.;
RT   "A novel mechanism in recessive nephrogenic diabetes insipidus: wild-
RT   type aquaporin-2 rescues the apical membrane expression of
RT   intracellularly retained AQP2-P262L.";
RL   Hum. Mol. Genet. 13:3045-3056(2004).
RN   [18]
RP   VARIANT ANDI LEU-254, AND CHARACTERIZATION OF VARIANT ANDI LEU-254.
RX   PubMed=16120822; DOI=10.1681/ASN.2005010104;
RA   de Mattia F., Savelkoul P.J.M., Kamsteeg E.-J., Konings I.B.M.,
RA   van der Sluijs P., Mallmann R., Oksche A., Deen P.M.T.;
RT   "Lack of arginine vasopressin-induced phosphorylation of aquaporin-2
RT   mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.";
RL   J. Am. Soc. Nephrol. 16:2872-2880(2005).
RN   [19]
RP   VARIANTS ANDI ASP-70 AND HIS-187.
RX   PubMed=16361827; DOI=10.3346/jkms.2005.20.6.1076;
RA   Cheong H.I., Cho S.J., Zheng S.H., Cho H.Y., Ha I.S., Choi Y.;
RT   "Two novel mutations in the aquaporin 2 gene in a girl with congenital
RT   nephrogenic diabetes insipidus.";
RL   J. Korean Med. Sci. 20:1076-1078(2005).
RN   [20]
RP   VARIANTS ANDI ARG-100 AND SER-180.
RX   PubMed=16845277; DOI=10.1097/01.gim.0000223554.46981.7a;
RA   Carroll P., Al-Mojalli H., Al-Abbad A., Al-Hassoun I., Al-Hamed M.,
RA   Al-Amr R., Butt A.I., Meyer B.F.;
RT   "Novel mutations underlying nephrogenic diabetes insipidus in Arab
RT   families.";
RL   Genet. Med. 8:443-447(2006).
RN   [21]
RP   INVOLVEMENT IN ANDI, VARIANT ANDI GLN-254, AND CHARACTERIZATION OF
RP   VARIANT ANDI GLN-254.
RX   PubMed=19585583; DOI=10.1002/humu.21082;
RA   Savelkoul P.J.M., De Mattia F., Li Y., Kamsteeg E.-J., Konings I.B.M.,
RA   van der Sluijs P., Deen P.M.T.;
RT   "p.R254Q mutation in the aquaporin-2 water channel causing dominant
RT   nephrogenic diabetes insipidus is due to a lack of arginine
RT   vasopressin-induced phosphorylation.";
RL   Hum. Mutat. 30:E891-E903(2009).
RN   [22]
RP   MISSORTING MOTIF OF VARIANT ANDI LYS-258.
RX   PubMed=19701945; DOI=10.1002/humu.21068;
RA   Kamsteeg E.-J., Stoffels M., Tamma G., Konings I.B.M., Deen P.M.T.;
RT   "Repulsion between Lys258 and upstream arginines explains the
RT   missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes
RT   insipidus.";
RL   Hum. Mutat. 30:1387-1396(2009).
RN   [23]
RP   VARIANT ANDI MET-108.
RX   PubMed=24944815; DOI=10.3892/br.2014.283;
RA   Park Y.J., Baik H.W., Cheong H.I., Kang J.H.;
RT   "Congenital nephrogenic diabetes insipidus with a novel mutation in
RT   the aquaporin 2 gene.";
RL   Biomed. Rep. 2:596-598(2014).
CC   -!- FUNCTION: Forms a water-specific channel that provides the plasma
CC       membranes of renal collecting duct with high permeability to
CC       water, thereby permitting water to move in the direction of an
CC       osmotic gradient.
CC   -!- INTERACTION:
CC       O43889-2:CREB3; NbExp=3; IntAct=EBI-12701138, EBI-625022;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:12194985}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12194985}. Basolateral cell membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cytoplasmic vesicle membrane {ECO:0000269|PubMed:12194985}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:12194985}. Golgi
CC       apparatus, trans-Golgi network membrane
CC       {ECO:0000269|PubMed:12194985}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12194985}. Note=Shuttles from vesicles to the
CC       apical membrane. Vasopressin-regulated phosphorylation is required
CC       for translocation to the apical cell membrane. PLEKHA8/FAPP2 is
CC       required to transport AQP2 from the TGN to sites where AQP2 is
CC       phosphorylated.
CC   -!- TISSUE SPECIFICITY: Expressed in renal collecting tubules.
CC   -!- DOMAIN: Aquaporins contain two tandem repeats each containing
CC       three membrane-spanning domains and a pore-forming loop with the
CC       signature motif Asn-Pro-Ala (NPA).
CC   -!- PTM: Ser-256 phosphorylation is necessary and sufficient for
CC       expression at the apical membrane. Endocytosis is not
CC       phosphorylation-dependent. {ECO:0000269|PubMed:12194985}.
CC   -!- DISEASE: Diabetes insipidus, nephrogenic, autosomal (ANDI)
CC       [MIM:125800]: A disorder caused by the inability of the renal
CC       collecting ducts to absorb water in response to arginine
CC       vasopressin. Characterized by excessive water drinking
CC       (polydipsia), excessive urine excretion (polyuria), persistent
CC       hypotonic urine, and hypokalemia. Inheritance can be autosomal
CC       dominant or recessive. {ECO:0000269|PubMed:12050236,
CC       ECO:0000269|PubMed:12191971, ECO:0000269|PubMed:15509592,
CC       ECO:0000269|PubMed:16120822, ECO:0000269|PubMed:16361827,
CC       ECO:0000269|PubMed:16845277, ECO:0000269|PubMed:19585583,
CC       ECO:0000269|PubMed:19701945, ECO:0000269|PubMed:24944815,
CC       ECO:0000269|PubMed:7524315, ECO:0000269|PubMed:8882880,
CC       ECO:0000269|PubMed:9048343, ECO:0000269|PubMed:9302264,
CC       ECO:0000269|PubMed:9402087, ECO:0000269|PubMed:9550615,
CC       ECO:0000269|PubMed:9649557, ECO:0000269|PubMed:9745427}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the MIP/aquaporin (TC 1.A.8) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z29491; CAA82627.1; -; Genomic_DNA.
DR   EMBL; D31846; BAA06632.1; -; Genomic_DNA.
DR   EMBL; S73196; AAB31999.1; -; mRNA.
DR   EMBL; S73197; AAB31998.1; -; mRNA.
DR   EMBL; AF147093; AAD38692.1; -; Genomic_DNA.
DR   EMBL; AF147092; AAD38692.1; JOINED; Genomic_DNA.
DR   EMBL; BC042496; AAH42496.1; -; mRNA.
DR   CCDS; CCDS8792.1; -.
DR   PIR; A53442; A53442.
DR   PIR; I64818; I64818.
DR   RefSeq; NP_000477.1; NM_000486.5.
DR   UniGene; Hs.130730; -.
DR   PDB; 4NEF; X-ray; 2.75 A; A/B/C/D=3-241.
DR   PDB; 4OJ2; X-ray; 3.05 A; X=1-271.
DR   PDBsum; 4NEF; -.
DR   PDBsum; 4OJ2; -.
DR   ProteinModelPortal; P41181; -.
DR   SMR; P41181; -.
DR   BioGrid; 106855; 1.
DR   IntAct; P41181; 3.
DR   STRING; 9606.ENSP00000199280; -.
DR   TCDB; 1.A.8.8.8; the major intrinsic protein (mip) family.
DR   iPTMnet; P41181; -.
DR   PhosphoSitePlus; P41181; -.
DR   BioMuta; AQP2; -.
DR   DMDM; 728874; -.
DR   PaxDb; P41181; -.
DR   PeptideAtlas; P41181; -.
DR   PRIDE; P41181; -.
DR   DNASU; 359; -.
DR   Ensembl; ENST00000199280; ENSP00000199280; ENSG00000167580.
DR   GeneID; 359; -.
DR   KEGG; hsa:359; -.
DR   UCSC; uc001rvn.4; human.
DR   CTD; 359; -.
DR   DisGeNET; 359; -.
DR   GeneCards; AQP2; -.
DR   GeneReviews; AQP2; -.
DR   HGNC; HGNC:634; AQP2.
DR   HPA; HPA046834; -.
DR   MalaCards; AQP2; -.
DR   MIM; 107777; gene.
DR   MIM; 125800; phenotype.
DR   neXtProt; NX_P41181; -.
DR   OpenTargets; ENSG00000167580; -.
DR   Orphanet; 223; Nephrogenic diabetes insipidus.
DR   PharmGKB; PA24920; -.
DR   eggNOG; KOG0223; Eukaryota.
DR   eggNOG; COG0580; LUCA.
DR   GeneTree; ENSGT00760000119223; -.
DR   HOGENOM; HOG000288286; -.
DR   HOVERGEN; HBG000312; -.
DR   InParanoid; P41181; -.
DR   KO; K09865; -.
DR   OMA; DHSPADY; -.
DR   OrthoDB; EOG091G166T; -.
DR   PhylomeDB; P41181; -.
DR   TreeFam; TF312940; -.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-432047; Passive transport by Aquaporins.
DR   GeneWiki; Aquaporin_2; -.
DR   GenomeRNAi; 359; -.
DR   PRO; PR:P41181; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000167580; -.
DR   CleanEx; HS_AQP2; -.
DR   ExpressionAtlas; P41181; baseline and differential.
DR   Genevisible; P41181; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IEA:Ensembl.
DR   GO; GO:0030658; C:transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0015168; F:glycerol transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015250; F:water channel activity; EXP:Reactome.
DR   GO; GO:0005372; F:water transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0071280; P:cellular response to copper ion; IDA:UniProtKB.
DR   GO; GO:0071288; P:cellular response to mercury ion; IDA:UniProtKB.
DR   GO; GO:0042631; P:cellular response to water deprivation; IEA:Ensembl.
DR   GO; GO:0007588; P:excretion; TAS:ProtInc.
DR   GO; GO:0015793; P:glycerol transport; IDA:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0072205; P:metanephric collecting duct development; IEA:Ensembl.
DR   GO; GO:0003091; P:renal water homeostasis; TAS:Reactome.
DR   GO; GO:0003097; P:renal water transport; IEA:Ensembl.
DR   GO; GO:0006833; P:water transport; IDA:UniProtKB.
DR   CDD; cd00333; MIP; 1.
DR   Gene3D; 1.20.1080.10; -; 1.
DR   InterPro; IPR023271; Aquaporin-like.
DR   InterPro; IPR034294; Aquaporin_transptr.
DR   InterPro; IPR000425; MIP.
DR   InterPro; IPR022357; MIP_CS.
DR   PANTHER; PTHR19139; PTHR19139; 1.
DR   Pfam; PF00230; MIP; 1.
DR   PRINTS; PR00783; MINTRINSICP.
DR   SUPFAM; SSF81338; SSF81338; 1.
DR   TIGRFAMs; TIGR00861; MIP; 1.
DR   PROSITE; PS00221; MIP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Cytoplasmic vesicle;
KW   Diabetes insipidus; Disease mutation; Glycoprotein; Golgi apparatus;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    271       Aquaporin-2.
FT                                /FTId=PRO_0000063934.
FT   TOPO_DOM      1     16       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     17     34       Helical. {ECO:0000255}.
FT   TOPO_DOM     35     40       Extracellular. {ECO:0000255}.
FT   TRANSMEM     41     59       Helical. {ECO:0000255}.
FT   TOPO_DOM     60     85       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     86    107       Helical. {ECO:0000255}.
FT   TOPO_DOM    108    127       Extracellular. {ECO:0000255}.
FT   TRANSMEM    128    148       Helical. {ECO:0000255}.
FT   TOPO_DOM    149    156       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    157    176       Helical. {ECO:0000255}.
FT   TOPO_DOM    177    202       Extracellular. {ECO:0000255}.
FT   TRANSMEM    203    224       Helical. {ECO:0000255}.
FT   TOPO_DOM    225    271       Cytoplasmic. {ECO:0000255}.
FT   MOTIF        68     70       NPA 1.
FT   MOTIF       184    186       NPA 2.
FT   MOD_RES     256    256       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:12194985}.
FT   CARBOHYD    123    123       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      22     22       L -> V (in ANDI; dbSNP:rs104894336).
FT                                {ECO:0000269|PubMed:9302264}.
FT                                /FTId=VAR_015239.
FT   VARIANT      28     28       L -> P (in ANDI).
FT                                {ECO:0000269|PubMed:12191971}.
FT                                /FTId=VAR_015240.
FT   VARIANT      47     47       A -> V (in ANDI).
FT                                {ECO:0000269|PubMed:12191971}.
FT                                /FTId=VAR_015241.
FT   VARIANT      57     57       Q -> P (in ANDI; dbSNP:rs28931580).
FT                                {ECO:0000269|PubMed:12050236}.
FT                                /FTId=VAR_015256.
FT   VARIANT      64     64       G -> R (in ANDI; dbSNP:rs104894326).
FT                                {ECO:0000269|PubMed:7524315}.
FT                                /FTId=VAR_004401.
FT   VARIANT      68     68       N -> S (in ANDI; dbSNP:rs104894331).
FT                                {ECO:0000269|PubMed:9048343}.
FT                                /FTId=VAR_015242.
FT   VARIANT      70     70       A -> D (in ANDI).
FT                                {ECO:0000269|PubMed:16361827}.
FT                                /FTId=VAR_062585.
FT   VARIANT      71     71       V -> M (in ANDI; dbSNP:rs149659001).
FT                                {ECO:0000269|PubMed:12191971}.
FT                                /FTId=VAR_015243.
FT   VARIANT     100    100       G -> R (in ANDI).
FT                                {ECO:0000269|PubMed:16845277}.
FT                                /FTId=VAR_062586.
FT   VARIANT     100    100       G -> V (in ANDI; dbSNP:rs28929477).
FT                                {ECO:0000269|PubMed:12050236}.
FT                                /FTId=VAR_015257.
FT   VARIANT     108    108       T -> M (in ANDI).
FT                                {ECO:0000269|PubMed:24944815}.
FT                                /FTId=VAR_071370.
FT   VARIANT     121    121       L -> F (in dbSNP:rs11169226).
FT                                /FTId=VAR_037577.
FT   VARIANT     125    125       T -> M (in ANDI; dbSNP:rs104894333).
FT                                {ECO:0000269|PubMed:12191971,
FT                                ECO:0000269|PubMed:9550615,
FT                                ECO:0000269|PubMed:9745427}.
FT                                /FTId=VAR_015244.
FT   VARIANT     126    126       T -> M (in ANDI; dbSNP:rs104894330).
FT                                {ECO:0000269|PubMed:9048343}.
FT                                /FTId=VAR_015245.
FT   VARIANT     147    147       A -> T (in ANDI; dbSNP:rs104894334).
FT                                {ECO:0000269|PubMed:9048343}.
FT                                /FTId=VAR_015246.
FT   VARIANT     168    168       V -> M (in ANDI; dbSNP:rs755694590).
FT                                {ECO:0000269|PubMed:9402087}.
FT                                /FTId=VAR_015247.
FT   VARIANT     175    175       G -> R (in ANDI; dbSNP:rs104894335).
FT                                {ECO:0000269|PubMed:12191971,
FT                                ECO:0000269|PubMed:9550615,
FT                                ECO:0000269|PubMed:9745427}.
FT                                /FTId=VAR_015248.
FT   VARIANT     180    180       G -> S (in ANDI).
FT                                {ECO:0000269|PubMed:16845277}.
FT                                /FTId=VAR_062587.
FT   VARIANT     181    181       C -> W (in ANDI; dbSNP:rs104894337).
FT                                {ECO:0000269|PubMed:9302264}.
FT                                /FTId=VAR_015249.
FT   VARIANT     185    185       P -> A (in ANDI; dbSNP:rs761713751).
FT                                {ECO:0000269|PubMed:12191971}.
FT                                /FTId=VAR_015250.
FT   VARIANT     187    187       R -> C (in ANDI; mutant protein does not
FT                                fold properly and is not functional;
FT                                dbSNP:rs104894328).
FT                                {ECO:0000269|PubMed:15509592,
FT                                ECO:0000269|PubMed:7524315}.
FT                                /FTId=VAR_004402.
FT   VARIANT     187    187       R -> H (in ANDI; dbSNP:rs193922495).
FT                                {ECO:0000269|PubMed:16361827}.
FT                                /FTId=VAR_062588.
FT   VARIANT     190    190       A -> T (in ANDI; mutant protein does not
FT                                fold properly and is not functional;
FT                                dbSNP:rs104894341).
FT                                {ECO:0000269|PubMed:15509592,
FT                                ECO:0000269|PubMed:9550615}.
FT                                /FTId=VAR_015251.
FT   VARIANT     194    194       V -> I (in dbSNP:rs772051028).
FT                                {ECO:0000269|PubMed:12191971}.
FT                                /FTId=VAR_015252.
FT   VARIANT     202    202       W -> C (in ANDI).
FT                                {ECO:0000269|PubMed:8882880}.
FT                                /FTId=VAR_015253.
FT   VARIANT     216    216       S -> P (in ANDI; dbSNP:rs104894329).
FT                                {ECO:0000269|PubMed:7524315,
FT                                ECO:0000269|PubMed:9402087}.
FT                                /FTId=VAR_004403.
FT   VARIANT     254    254       R -> L (in ANDI; results in the loss of
FT                                arginine vasopressin-mediated
FT                                phosphorylation at S-256).
FT                                {ECO:0000269|PubMed:16120822}.
FT                                /FTId=VAR_062589.
FT   VARIANT     254    254       R -> Q (in ANDI; exerts a dominant-
FT                                negative effect on wild-type-AQP2 in that
FT                                it interferes with its trafficking to the
FT                                apical membrane; is a loss of function
FT                                instead of a gain of function mutation on
FT                                dominant nephrogenic diabetes insipidus).
FT                                {ECO:0000269|PubMed:19585583}.
FT                                /FTId=VAR_062590.
FT   VARIANT     258    258       E -> K (in ANDI; retained in the Golgi
FT                                compartment; dbSNP:rs104894332).
FT                                {ECO:0000269|PubMed:19701945,
FT                                ECO:0000269|PubMed:9649557}.
FT                                /FTId=VAR_015254.
FT   VARIANT     262    262       P -> L (in ANDI; mutant protein folds
FT                                properly and is functional but is
FT                                retained in intracellular vesicles and
FT                                does not localize to the ER; upon
FT                                coexpression with wild-type AQP2 mutant
FT                                protein interacts with wild-type AQP2 and
FT                                the resulting heterotetramer properly
FT                                localizes to the apical membrane;
FT                                dbSNP:rs104894339).
FT                                {ECO:0000269|PubMed:15509592,
FT                                ECO:0000269|PubMed:9550615}.
FT                                /FTId=VAR_015255.
FT   MUTAGEN     148    148       S->A: No effect on sorting from the ER to
FT                                the vesicles, redistribution to apical
FT                                membrane, or endocytosis.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     148    148       S->D: Retained in the endoplasmic
FT                                reticulum. {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     229    229       S->A: No effect on sorting from the ER to
FT                                the vesicles, redistribution to apical
FT                                membrane, or endocytosis.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     229    229       S->D: No effect on sorting from the ER to
FT                                the vesicles, redistribution to apical
FT                                membrane, or endocytosis.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     231    231       S->A: No effect on sorting from the ER to
FT                                the vesicles, redistribution to apical
FT                                membrane, or endocytosis.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     231    231       S->D: No effect on sorting from the ER to
FT                                the vesicles, redistribution to apical
FT                                membrane, or endocytosis.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     244    244       T->A: No effect on sorting from the ER to
FT                                the vesicles, redistribution to apical
FT                                membrane, or endocytosis.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     244    244       T->E: No effect on sorting from the ER to
FT                                the vesicles, redistribution to apical
FT                                membrane, or endocytosis.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     256    256       S->A: Retained in vesicles.
FT                                {ECO:0000269|PubMed:12194985}.
FT   MUTAGEN     256    256       S->D: Expressed in the apical membrane.
FT                                {ECO:0000269|PubMed:12194985}.
FT   CONFLICT     35     38       PQAL -> ATAP (in Ref. 4). {ECO:0000305}.
FT   CONFLICT     83     83       V -> F (in Ref. 4). {ECO:0000305}.
FT   HELIX         7     32       {ECO:0000244|PDB:4NEF}.
FT   STRAND       35     37       {ECO:0000244|PDB:4NEF}.
FT   HELIX        41     63       {ECO:0000244|PDB:4NEF}.
FT   HELIX        69     77       {ECO:0000244|PDB:4NEF}.
FT   HELIX        83    107       {ECO:0000244|PDB:4NEF}.
FT   HELIX       110    113       {ECO:0000244|PDB:4NEF}.
FT   HELIX       127    148       {ECO:0000244|PDB:4NEF}.
FT   HELIX       159    179       {ECO:0000244|PDB:4NEF}.
FT   HELIX       185    195       {ECO:0000244|PDB:4NEF}.
FT   TURN        199    202       {ECO:0000244|PDB:4NEF}.
FT   HELIX       203    221       {ECO:0000244|PDB:4NEF}.
FT   HELIX       232    237       {ECO:0000244|PDB:4NEF}.
SQ   SEQUENCE   271 AA;  28837 MW;  C2DDE2AF4DDD192A CRC64;
     MWELRSIAFS RAVFAEFLAT LLFVFFGLGS ALNWPQALPS VLQIAMAFGL GIGTLVQALG
     HISGAHINPA VTVACLVGCH VSVLRAAFYV AAQLLGAVAG AALLHEITPA DIRGDLAVNA
     LSNSTTAGQA VTVELFLTLQ LVLCIFASTD ERRGENPGTP ALSIGFSVAL GHLLGIHYTG
     CSMNPARSLA PAVVTGKFDD HWVFWIGPLV GAILGSLLYN YVLFPPAKSL SERLAVLKGL
     EPDTDWEERE VRRRQSVELH SPQSLPRGTK A
//
